(Q43523129)

24 November 2017

title

A clinical perspective on gastric neuroendocrine neoplasia (English)

1 reference

24 November 2017

4

Irvin Modlin

1 reference

24 November 2017

Ben Lawrence

1

1 reference

24 November 2017

Mark Kidd

series ordinal

2

1 reference

24 November 2017

Bernhard Svejda

series ordinal

3

1 reference

24 November 2017

publication date

1 February 2011

1 reference

Current gastroenterology reports

24 November 2017

published in

1 reference

24 November 2017

volume

13

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

101-109

1 reference

Carcinoid tumors of the stomach

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Primary gastric small cell carcinoma: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Biology and management of gastric carcinoid tumours: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Current status of gastrointestinal carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Well-differentiated gastric tumors/carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Gastrin is the most important factor in ECL tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Double balloon enteroscopy in children: diagnosis, treatment, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Long-term proton pump inhibitor use and gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Proton pump inhibitors and gastric neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

The NANETS Consensus Guidelines for the Diagnosis and Management of Poorly Differentiated (High-Grade) Extrapulmonary Neuroendocrine Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Defining surgical indications for type I gastric carcinoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a mastomys rodent model of gastric neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Treatment of type I gastric neuroendocrine tumors with somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

One-year follow-up study of patients with enterochromaffin-like cell carcinoids after treatment with octreotide long-acting release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Long-term treatment with octreotide in patients with the Zollinger-Ellison syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

A 5-decade analysis of 13,715 carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Accuracy of EUS in the evaluation of small gastric subepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11894-010-0158-4

Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia

21 January 2018

1 reference

12 December 2020

A Proposed Staging System for Gastric Carcinoid Tumors Based on an Analysis of 1,543 Patients

1 reference

12 December 2020

Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases

1 reference

12 December 2020

Diagnosis and management of gastric carcinoid tumour with hepatic metastases

1 reference

12 December 2020

Development of carcinoid tumors of the glandular stomach and effects of eradication in Helicobacter pylori-infected Mongolian gerbils

1 reference

12 December 2020

Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment

1 reference

12 December 2020

A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies

1 reference

12 December 2020

Safety of the long-term use of proton pump inhibitors

1 reference

12 December 2020

Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses

1 reference

12 December 2020

Unusual multiple gastric carcinoids with hypergastrinemia: report of a case

1 reference

12 December 2020

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis

1 reference

12 December 2020

Prognosis of gastric carcinoid tumours

1 reference

12 December 2020

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

1 reference

12 December 2020

The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy

1 reference

12 December 2020

Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.

1 reference

12 December 2020

Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1

1 reference

12 December 2020

Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: A clinicopathologic study

1 reference

12 December 2020

Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.

1 reference

12 December 2020

Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type

1 reference

12 December 2020

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach.

1 reference

12 December 2020

Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispidus)

1 reference

12 December 2020

New Pharmacologic Therapies for Gastroenteropancreatic Neuroendocrine Tumors

1 reference

12 December 2020

10.1007/S11894-010-0158-4

Identifiers

DOI

1 reference

24 November 2017

1 reference